awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A
Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A
Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities.
P2860
Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42930387-418401E1-6AF6-4DA3-8B5C-84419A59483A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09ea86d16cad08d2311e39d41e41c30cbcc9bfcc
P2860
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily